ARRY
Price
$5.84
Change
-$0.00 (-0.00%)
Updated
Aug 8 closing price
Capitalization
890.87M
89 days until earnings call
INO
Price
$1.41
Change
-$0.03 (-2.08%)
Updated
Aug 8 closing price
Capitalization
71.85M
Interact to see
Advertisement

ARRY vs INO

Header iconARRY vs INO Comparison
Open Charts ARRY vs INOBanner chart's image
Array Technologies
Price$5.84
Change-$0.00 (-0.00%)
Volume$355.02K
Capitalization890.87M
Inovio Pharmaceuticals
Price$1.41
Change-$0.03 (-2.08%)
Volume$396.56K
Capitalization71.85M
ARRY vs INO Comparison Chart in %
Loading...
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRY vs. INO commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a StrongBuy and INO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2025
Stock price -- (ARRY: $5.50 vs. INO: $1.41)
Brand notoriety: ARRY: Not notable vs. INO: Notable
ARRY represents the Alternative Power Generation, while INO is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARRY: 189% vs. INO: 22%
Market capitalization -- ARRY: $890.87M vs. INO: $71.85M
ARRY [@Alternative Power Generation] is valued at $890.87M. INO’s [@Biotechnology] market capitalization is $71.85M. The market cap for tickers in the [@Alternative Power Generation] industry ranges from $118.24B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Alternative Power Generation] industry is $1.6B. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRY’s FA Score shows that 1 FA rating(s) are green whileINO’s FA Score has 0 green FA rating(s).

  • ARRY’s FA Score: 1 green, 4 red.
  • INO’s FA Score: 0 green, 5 red.
According to our system of comparison, INO is a better buy in the long-term than ARRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRY’s TA Score shows that 4 TA indicator(s) are bullish while INO’s TA Score has 3 bullish TA indicator(s).

  • ARRY’s TA Score: 4 bullish, 6 bearish.
  • INO’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, ARRY is a better buy in the short-term than INO.

Price Growth

ARRY (@Alternative Power Generation) experienced а -9.24% price change this week, while INO (@Biotechnology) price change was -1.40% for the same time period.

The average weekly price growth across all stocks in the @Alternative Power Generation industry was -0.77%. For the same industry, the average monthly price growth was -2.88%, and the average quarterly price growth was +12.38%.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

ARRY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Alternative Power Generation (-0.77% weekly)

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARRY($891M) has a higher market cap than INO($71.9M). ARRY YTD gains are higher at: -8.940 vs. INO (-20.787). INO has higher annual earnings (EBITDA): -93.37M vs. ARRY (-148.26M). ARRY has more cash in the bank: 348M vs. INO (68.4M). INO has less debt than ARRY: INO (11.3M) vs ARRY (679M). ARRY has higher revenues than INO: ARRY (1.07B) vs INO (283K).
ARRYINOARRY / INO
Capitalization891M71.9M1,239%
EBITDA-148.26M-93.37M159%
Gain YTD-8.940-20.78743%
P/E Ratio56.91N/A-
Revenue1.07B283K376,325%
Total Cash348M68.4M509%
Total Debt679M11.3M6,009%
FUNDAMENTALS RATINGS
ARRY vs INO: Fundamental Ratings
ARRY
INO
OUTLOOK RATING
1..100
5115
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
8565
P/E GROWTH RATING
1..100
29100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (49) in the Medical Specialties industry is somewhat better than the same rating for ARRY (92) in the Biotechnology industry. This means that INO’s stock grew somewhat faster than ARRY’s over the last 12 months.

INO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ARRY (100) in the Biotechnology industry. This means that INO’s stock grew similarly to ARRY’s over the last 12 months.

INO's SMR Rating (99) in the Medical Specialties industry is in the same range as ARRY (100) in the Biotechnology industry. This means that INO’s stock grew similarly to ARRY’s over the last 12 months.

INO's Price Growth Rating (65) in the Medical Specialties industry is in the same range as ARRY (85) in the Biotechnology industry. This means that INO’s stock grew similarly to ARRY’s over the last 12 months.

ARRY's P/E Growth Rating (29) in the Biotechnology industry is significantly better than the same rating for INO (100) in the Medical Specialties industry. This means that ARRY’s stock grew significantly faster than INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRYINO
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ARRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EPGAX21.51N/A
N/A
Fidelity Advisor Equity Growth A
ABYSX21.30N/A
N/A
AB Discovery Value Advisor
HRTVX49.76N/A
N/A
Heartland Value Investor
NBRCX25.38N/A
N/A
Neuberger Berman M/C Intrinsic Val C
VPRDX13.75N/A
N/A
VY® Morgan Stanley Global Franchise R6